AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,442,000 | +44.8% | 41,200 | +179.0% | 0.04% | +54.2% |
| Q1 2019 | $996,000 | +60.4% | 14,765 | +100.2% | 0.02% | +118.2% |
| Q2 2018 | $621,000 | -32.2% | 7,375 | -34.2% | 0.01% | -21.4% |
| Q1 2018 | $916,000 | -33.3% | 11,200 | -45.6% | 0.01% | -26.3% |
| Q3 2017 | $1,374,000 | +12.2% | 20,574 | -1.9% | 0.02% | +26.7% |
| Q1 2017 | $1,225,000 | -61.7% | 20,977 | -27.0% | 0.02% | -75.8% |
| Q2 2015 | $3,195,000 | – | 28,750 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |